BiotechTube

Teriparatide + Strontium ranelate

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Postmenopausal Osteoporosis

Conditions

Postmenopausal Osteoporosis

Trial Timeline

Sep 1, 2005 → Jan 1, 2007

NCT ID
NCT00239629

About Teriparatide + Strontium ranelate

Teriparatide + Strontium ranelate is a approved stage product being developed by Eli Lilly for Postmenopausal Osteoporosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00239629. Target conditions include Postmenopausal Osteoporosis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00239629ApprovedCompleted

Competing Products

20 competing products in Postmenopausal Osteoporosis

See all competitors
ProductCompanyStageHype Score
ENZ215 + ProliaAlkem LaboratoriesPhase 3
77
teriparatide + teriparatide + Placebo + Calcium Supplement + Vitamin D SupplementEli LillyPhase 3
77
teriparatide 20 micrograms/day subcutaneous + salmon calcitonin 100 IU/day subcutaneousEli LillyPhase 3
77
CT-P41 + US-licensed ProliaCelltrionPhase 3
77
LetrozoleChugai PharmaceuticalPhase 2
52
Eldecalcitol soft capsulesChugai PharmaceuticalPre-clinical
23
LetrozoleChugai PharmaceuticalPhase 2
52
LetrozoleChugai PharmaceuticalPhase 2
52
menatetranone + alfacalcidolEisaiPhase 3
77
teriparatide + raloxifene + placeboEli LillyPhase 3
77
teriparatideEli LillyApproved
85
LY333334 + PlaceboEli LillyPhase 1
33
Teriparatide + RaloxifeneEli LillyApproved
85
teriparatide + aldrenodate + raloxifeneEli LillyApproved
85
LAE102 SC + Placebo SC + LAE102 IV + Placebo IVEli LillyPhase 1
33
BlosozumabEli LillyPhase 1
33
BlosozumabEli LillyPhase 1
33
Arzoxifene + RaloxifeneEli LillyPhase 3
77
teriparatide + raloxifene HCl + placeboEli LillyApproved
85
Raloxifene HCL + Raloxifene HCL + PlaceboEli LillyPhase 3
77

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85